New Hope, Funding Approaches As Roche Brings Evrysdi To India
Zolgensma Provided In India Through Managed Access Program
Roche’s Evrysdi debuts in India backed by a patient support program ahead of Novartis’ Zolgensma and Biogen’s Spinraza. Spotlights remains on the price tag for the SMA therapy amid hopes that novel approaches such as crowdfunding could also broaden access.
